Final analysis of a phase II study of modified FOLFIRINOX in locally advanced and metastatic pancreatic cancer

BACKGROUND: Modifications of FOLFIRINOX are widely used despite the absence of prospective data validating efficacy in metastatic disease (metastatic pancreatic cancer (MPC)) or locally advanced pancreatic cancer (LAPC). We conducted a multicentre phase II study of modified FOLFIRINOX in advanced pa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Cancer
Main Authors: Stein, Stacey M, James, Edward S, Deng, Yanhong, Cong, Xiangyu, Kortmansky, Jeremy S, Li, Jia, Staugaard, Carol, Indukala, Doddamane, Boustani, Ann Marie, Patel, Vatsal, Cha, Charles H, Salem, Ronald R, Chang, Bryan, Hochster, Howard S, Lacy, Jill
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2016
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4984865/
https://ncbi.nlm.nih.gov/pubmed/27022826
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2016.45
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados